Belapzo belongs to the group of drugs used to treat cancer and contains Bendamustine, which is administered intravenously. Belapzo is indicated for the treatment of chronic Lymphocytic leukemia and B-cell non-Hodgkin's lymphoma in patients already receiving other therapies.